FDA Approval of EMFLAZA for Treatment of Duchenne's Muscular Dystrophy

News   Feb 21, 2017 | Original Story From Marathon Pharmaceuticals, LLC.

 
FDA Approval of EMFLAZA for Treatment of Duchenne's Muscular Dystrophy
 
 
 

RELATED ARTICLES

Understanding Lung Cancer Cell Networks Helps Create Drug Treatments

News

A team of scientists has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

READ MORE

Biomaterial Helps Brain Tissue Regrow After Stroke

News

A new stroke-healing gel created by UCLA researchers helped regrow neurons and blood vessels in mice whose brains had been damaged by strokes.

READ MORE

Ataxin Links Long Term-Memory and Neurodegeneration

News

Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in motor neuron disease (MND)

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE